In the European diabetes care devices market, Germany accounted for approximately 21.9% of the total market value in 2019. The diabetes care device market in Germany is expected to register a CAGR of more than 8% during the forecast period. Germany is one of the developed countries and advanced in terms of healthcare facilities. Technologies, such as continuous glucose monitoring and insulin infusion pumps, are getting adopted rapidly in Germany than the other developing countries. Moreover, the reimbursement policy and the pricing policy are highly regulated, which drive the market and increase the adoption rate of new and advanced technologies. The roll-out of many new drugs, increasing international research collaborations in technology advancement, and increasing awareness about diabetes among the people are some of the market opportunities for the players in the German diabetes care device market.
Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-88663
Key Market Trends
The Monitoring Devices Segment Occupied the Highest Market Share in the German Diabetes Care Devices Market in 2019
Monitoring devices include self-monitoring blood glucose devices (SMBG) and continuous glucose monitoring devices (CGM), where SMBG devices held the highest share in 2019, with a revenue of USD 0.9 billion. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. Type-1 diabetic patients need to check their blood glucose levels at regular intervals, in order to monitor their blood glucose levels and adjust the insulin dosing accordingly. Therefore, if a patient performs 5-6 tests in a day, the average expenditure on test strips may be more than USD 100/month. These expenses add to the already high costs of diabetes management, and they are impeding market growth. The current CGM devices show a detailed representation of blood glucose patterns and tendencies compared to a routine check of glucose levels at set intervals.
Disposable Insulin Pens Hold the Highest Market Share Among Insulin Delivery Devices
Insulin disposable pens are the most widely used devices for the administration of insulin in Germany. This sub-segment occupies more than 55% of the share in the management devices segment and around 13% of the market share in the whole diabetes care devices market. Insulin cartridges in reusable pens are known to be a needed extension to insulin pens. These devices are considered to be an upgraded version of the insulin vials. Most types of insulins are manufactured in the form of cartridges, thus, making it easily accessible. These devices have all the functional benefits of reusable pens and are cost-effective, as these cartridges are less expensive compared to disposable insulin pens. Due to the increasing demand for insulin cartridges, most of the insulin device manufacturing companies have produced reusable insulin pens that are compatible with various insulin manufacturers’ cartridges. These insulin cartridges are considered to be more socially friendly, as they are smaller and less noticeable than the classic vial-and-syringe. They are also more portable for consumers on-the-go. Cartridges that are open do not need to be refrigerated, thus, making the storage very easy for consumers. Therefore, using cartridges is the most cost-effective way to use insulin, as reusable pens are a one-time investment, unlike disposable pens.
Germany Diabetes Care Devices Market Size: Dynamics, Segments, and Demand Analysis Forecast 2022-2031
Europe Nuclear Medicine Market Size: Facts, Figures and Analytical Insights Forecast 2022-2031
Biomaterials Market Size Insights on Share, Application and Forecast Assumptions 2022-2031
Wearable Medical Devices Market Size Analysis & Growth Opportunities Forecast 2022-2031
Middle East & Africa General Surgical Devices Market Size Projected to Deliver Greater Revenues during the Forecast Period 2022-2031
